[Changes in blood viscosity concomitant with prazosin therapy in patients with essential arterial hypertension].
D000328:Adult; D000450:Aldosterone / Q000652:urine; D001794:Blood Pressure / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects*; D003404:Creatinine / Q000378:metabolism; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000652:urine; D011224:Prazosin / Q000494:pharmacology* / Q000627:therapeutic use; D011799:Quinazolines / Q000494:pharmacology*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine
D011799:Quinazolines; D011942:Receptors, Adrenergic, alpha; D000450:Aldosterone; D012964:Sodium; D003404:Creatinine; D012083:Renin; D011188:Potassium; D011224:Prazosin
Cambios de la viscosidad sanguínea concomitantes a la terapia con prazosin en pacientes con hipertensión arterial esencial.